Caprock Group’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Buy
14,437
+506
+4% +$3.91K ﹤0.01% 1189
2026
Q1
$88.7K Sell
13,931
-4,626
-25% -$32.2K ﹤0.01% 1087
2025
Q4
$131K Buy
+18,557
New +$112K ﹤0.01% 1144
2024
Q3
Sell
-10,062
Closed -$49.4K 946
2024
Q2
$49.4K Hold
10,062
﹤0.01% 842
2024
Q1
$62.1K Sell
10,062
-58,473
-85% -$394K ﹤0.01% 706
2023
Q4
$537K Hold
68,535
0.03% 370
2023
Q3
$471K Sell
68,535
-63
-0.1% -$511 0.04% 372
2023
Q2
$626K Buy
68,598
+125
+0.2% +$1.04K 0.05% 312
2023
Q1
$509K Hold
68,473
0.04% 356
2022
Q4
$338K Hold
68,473
0.03% 367
2022
Q3
$453K Sell
68,473
-41,527
-38% -$290K 0.04% 298
2022
Q2
$612K Buy
110,000
+10,000
+10% +$76.6K 0.06% 235
2022
Q1
$1.01M Buy
100,000
+40,000
+67% +$351K 0.1% 169
2021
Q4
$571K Buy
60,000
+15,000
+33% +$159K 0.05% 256
2021
Q3
$653K Buy
+45,000
New +$867K 0.06% 219

Other funds holding LFST

Caprock Group's LFST Position: Q2 2026 in Review

Caprock Group increased its Lifestance Health (LFST) stake by 3.6% in Q2 2026, buying an estimated $3.91K and bringing the position to 14,437 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Caprock Group first reported a position in LFST in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.01M in Q1 2022. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Caprock Group held 14,437 shares of Lifestance Health worth $155K as of Q2 2026.
  • Caprock Group bought 506 Lifestance Health shares in Q2 2026, an estimated $3.91K.
  • Lifestance Health made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1189 holding.
  • Caprock Group first reported a position in Lifestance Health in Q3 2021 and has held it in 15 quarters since.
  • Caprock Group's Lifestance Health position peaked at $1.01M in Q1 2022.
  • 289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.